AbbVie (ABBV) Tops Q4 EPS by 1c

AbbVie (NYSE: ABBV) reported Q4 EPS of $1.20, $0.01 better than the analyst estimate of $1.19. Revenue for the quarter came in at $6.78 billion versus the consensus estimate of $6.92 billion.

For earnings history and earnings-related data on AbbVie (ABBV) click here.

You May Also Be Interested In

• Wells Fargo cuts Netflix rating on engagement risk, weak slate
• Is the S&P 500 in an "earnings bubble"? Goldman weighs in
• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2